Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CTLA4 Antikörper

Der Maus Monoklonal anti-CTLA4 Antikörper (Klon rCTLA4-7219) (ABIN7861192) detektiert spezifisch CTLA4 in IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN7861192
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter CTLA4 Antikörper (ABIN7861192)

Target

Alle CTLA4 Antikörper anzeigen
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 194
  • 119
  • 55
  • 15
  • 10
  • 2
Human

Wirt

  • 108
  • 106
  • 23
  • 22
  • 10
  • 3
  • 2
  • 1
  • 1
Maus

Klonalität

  • 203
  • 70
  • 3
Monoklonal

Konjugat

  • 138
  • 22
  • 21
  • 20
  • 15
  • 7
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CTLA4 Antikörper ist unkonjugiert

Applikation

  • 105
  • 87
  • 67
  • 51
  • 36
  • 29
  • 28
  • 16
  • 13
  • 10
  • 7
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

RCTLA4-7219
  • Verwendungszweck

    Recombinant CTLA4 / CD152 (Negative Regulator of T-Cells) Antibody

    Spezifität

    Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is a member of the CD28 superfamily and is a negative regulator of T cell-mediated immune responses. CTLA-4 expression is induced on the surface of T cells after CD28 binding and activation, and is constitutively expressed on T-regulatory cells, acting as an immune checkpoint inhibitor, downregulating T cell activity. CTLA-4 primarily inactivates T-cell activity by competing with the CD28 costimulatory molecule. CD28 and CTLA-4 share the identical ligands of CD80 and CD86 on antigenpresenting cells, and thus CTLA-4 competes with CD28 function in T-cell survival, proliferation, and recruitment. In particular, CTLA-4 down-modulates CD4+ helper T-cell activity and enhances Treg immunosuppressive functions. CTLA-4 has been shown to play a role in human diseases. CTLA-4 acts as a physiological brake on the activated immune system in order to maintain immune homeostasis. Several suppressive mechanisms for T-cell functions have been attributed to CTLA-4.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment of human CTLA4 (exact sequence is proprietary)

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Andere Bezeichnung

    CTLA4

    Hintergrund

    ALPS5, CD152, Celiac disease 3 (CELIAC3), Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), GRD4, GSE, ICOS, Insulin-dependent Diabetes Mellitus 12 (IDDM12)

    Jurkat or Raji cells. Lymph node or tonsil.

    Molekulargewicht

    30-43kDa

    Gen-ID

    1493, 247824

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!